Vaccine renaissance

descriptionPublicationkeyboard_double_arrow_right Article 01 Jul 2007 English Publisher:Springer Science and Business Media LLCJournal:Nature Reviews Microbiology, volume 5, pages 478-481 (issn: 1740-1526, eissn: 1740-1534,

Copyright policy )

Authors: Jeffrey W, Almond;

doi: 10.1038/nrmicro1702

pmid: 17571456

Vaccine renaissance

- Summary
- Subjects
- Metrics

Abstract

Vaccines are one of the most useful and cost-effective tools for reducing the morbidity and mortality that are associated with infectious diseases. Here, Jeffrey Almond discusses the selection of articles in this Focus issue, in the context of the challenges and opportunities facing vaccine developers today.

Related Organizations

Sanofi (France)
France

Keywords

Vaccines, Public Sector, Research, Disease Outbreaks, Child, Preschool, Drug Design, Communicable Disease Control, Animals, Humans, Private Sector, Child

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	16
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%